Moreover, the TMB was significantly different among cancers with multiple MCM2 mutations (364, 313.9–414.08), truncating MCM2 mutations (17.5, 8.84–30.89) and missense MCM2 mutations (35.63, 10.65–90.36; Figure 5E). This evidence concerns the gene MCM2 and cancer.